#apogee Tech News.
1 story in the last 7 days
The latest apogee news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks apogee across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.
AITheStreetabout 4 hours ago
AbbVie's biggest deal since 2019 could land soonAbbVie is closing in on a $10.9 billion cash deal to buy Apogee Therapeutics, a roughly 60% premium to Apogee's share price. The biotech has no approved drugs and is years from its first launch, an unusual target for AbbVie. An announcement could come as early as Monday.
Summaries by ByteBrief